JKF-13245-25989
2 vaccinations
6 coded responses
11 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 200 / DC
- Registered
- 2021-09-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-09-27
Registered in v-safe
-
2021-09-27
Dose 2 — Janssen/Johnson & Johnson
-
2021-09-27
Survey response — day 0, dose 2MedDRA: Lip pruritus, Throat irritation — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Itchiness in throat and lipsMedDRA releases: 2024-11 · check-in free text available
-
2021-09-28
Survey response — days 1–6 daily, dose 2MedDRA: Chest discomfort, Throat irritation — Feeling: Poor · Chills, Headache, Joint pains, Muscle or body aches, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Itchy throat and heavy chestMedDRA releases: 2024-11 · check-in free text available
-
2021-09-28
Report sent to call center — days 1–6 daily, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2021-09-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-30
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Poor · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesFree text: LightheadedMedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Call successfulParticipant prefers to complete VAERS report online
-
2021-10-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-10-04
-
2021-10-21
Survey response — day 21, dose 2MedDRA: Anxiety — Feeling: GoodFree text: Increased anxietyMedDRA releases: 2024-11 · check-in free text available
- 2021-11-03
- 2021-12-29
-
2022-03-31
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-03-31
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-04-04
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-27
Survey response — 12 months, dose 2MedDRA: Malaise — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: COVID symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
-
2022-09-28
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | No |
| 2 | 2021-09-27 | Janssen/Johnson & Johnson | No |
Call center
3 call center cases
3 successful
Free text
Release 9 — day 0, dose 2
Systemic reaction (other): Itchiness in throat and lips
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Itchy throat and heavy chest
Systemic reaction (other): Lightheaded
Release 10 — day 21, dose 2
Symptoms: Increased anxiety
Release 11 — 6 months, dose 2
Symptoms: Pregnancy
Release 12 — 12 months, dose 2
Symptoms: COVID symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Chest discomfort | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Lip pruritus | · | · | ✓ |
| SRO | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release